These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 21096014)

  • 21. Power and sample size when multiple endpoints are considered.
    Senn S; Bretz F
    Pharm Stat; 2007; 6(3):161-70. PubMed ID: 17674404
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exact tests using two correlated binomial variables in contemporary cancer clinical trials.
    Yu J; Kepner JL; Iyer R
    Biom J; 2009 Dec; 51(6):899-914. PubMed ID: 20014199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The potential for increased power from combining P-values testing the same hypothesis.
    Ganju J; Julie Ma G
    Stat Methods Med Res; 2017 Feb; 26(1):64-74. PubMed ID: 24919832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bayesian multiple testing for two-sample multivariate endpoints.
    Gönen M; Westfall PH; Johnson W
    Biometrics; 2003 Mar; 59(1):76-82. PubMed ID: 12762443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple comparisons with a control for a latent variable model with ordered categorical responses.
    Lu TY; Poon WY; Cheung SH
    Stat Methods Med Res; 2015 Dec; 24(6):949-67. PubMed ID: 22267547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progressing towards acceptable treatment outcomes.
    Vowles KE; Robinson ME
    Pain; 2009 Aug; 144(3):228-229. PubMed ID: 19500909
    [No Abstract]   [Full Text] [Related]  

  • 27. Adaptive Designs with Discrete Test Statistics and Consideration of Overrunning.
    Schmidt R; Burkhardt B; Faldum A
    Methods Inf Med; 2015; 54(5):434-46. PubMed ID: 26429500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Closed testing using surrogate hypotheses with restricted alternatives.
    Lachin JM; Bebu I; Larsen MD; Younes N
    PLoS One; 2019; 14(7):e0219520. PubMed ID: 31299051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predicting probability of mortality in the neonatal intensive care unit.
    Zhou D; Frize M
    Conf Proc IEEE Eng Med Biol Soc; 2006; 2006():2308-11. PubMed ID: 17945705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Group sequential testing in clinical trials with multivariate observations: a review.
    Lee JW
    Stat Med; 1994 Jan; 13(2):101-11. PubMed ID: 8122047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A nonparametric comparison of the effectiveness of treatments: a multivariate toxicity-penalized approach.
    Tubert-Bitter P; Letierce A; Bloch DA; Kramar A
    J Biopharm Stat; 2005; 15(1):129-42. PubMed ID: 15702609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Applications of the Wei-Lachin multivariate one-sided test for multiple outcomes on possibly different scales.
    Lachin JM
    PLoS One; 2014; 9(10):e108784. PubMed ID: 25329662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A nonparametric method to detect increased frequencies of adverse drug reactions over time.
    Heimann G; Belleli R; Kerman J; Fisch R; Kahn J; Behr S; Berlin C
    Stat Med; 2018 Apr; 37(9):1491-1514. PubMed ID: 29322542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of the Wei-Lachin multivariate one-directional test to multiple event-time outcomes.
    Lachin JM; Bebu I
    Clin Trials; 2015 Dec; 12(6):627-33. PubMed ID: 26336199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Power considerations for clinical trials using multivariate time-to-event data.
    Hughes MD
    Stat Med; 1997 Apr; 16(8):865-82. PubMed ID: 9160485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of methods for early-readmission prediction in a high-dimensional heterogeneous covariates and time-to-event outcome framework.
    Bussy S; Veil R; Looten V; Burgun A; Gaïffas S; Guilloux A; Ranque B; Jannot AS
    BMC Med Res Methodol; 2019 Mar; 19(1):50. PubMed ID: 30841867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Futility interim monitoring with control of type I and II error probabilities using the interim Z-value or confidence limit.
    Lachin JM
    Clin Trials; 2009 Dec; 6(6):565-73. PubMed ID: 19933716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How to Compare the Length of Stay of Two Samples of Inpatients? A Simulation Study to Compare Type I and Type II Errors of 12 Statistical Tests.
    Chazard E; Ficheur G; Beuscart JB; Preda C
    Value Health; 2017; 20(7):992-998. PubMed ID: 28712630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A note on the power of Fisher's least significant difference procedure.
    Meier U
    Pharm Stat; 2006; 5(4):253-63. PubMed ID: 17128424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A simplified method of calculating an overall goodness-of-fit test for the Cox proportional hazards model.
    May S; Hosmer DW
    Lifetime Data Anal; 1998; 4(2):109-20. PubMed ID: 9658770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.